belyaevostapuki.blogspot.com
Genzyme (NASDAQ: GENZ) found a virus strain and stopped production of two drugsa atthe Allston, Mass., facility. The Vesivirus 2117, apparently does not cause human infection but interruptw the growth of cells that are used tomake drugs. Aldurazymed — a treatment for MPS I, a rare and fata disease caused by an enzymedeficiencyt — was last filledx at the Genzyme facility in Septemberf 2008, according to BioMarin (NASDAQ: BMRN). The company has about 10 month s of vialed inventoryon hand, it and uses a second fill finish supplier. A thirxd supplier is expected to be qualifies laterthis year, BioMarijn said.
BioMarin makes the bulk material used in Aldurazymer at itsNovato facility. The Food and Drug Administration hadinspected Genzyme’s plant in September and Octoberf and reportedly was concerned about controls to protect against contamination.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment